Tharimmune, Inc. (THAR)
(Delayed Data from NSDQ)
$1.26 USD
+0.05 (4.13%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $1.26 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Tharimmune, Inc. has a market cap of $5.11M, which represents its share price of $1.21 multiplied by its outstanding shares number of 4.22M. As a small-cap company, THAR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
THAR 1.26 +0.05(4.13%)
Will THAR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for THAR based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for THAR
Tharimmune (THAR) Welcomes Philanthropist Nancy Davis to Board of Directors
Tharimmune appoints Nancy Davis to board of directors
Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now ...
Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors
Tharimmune (THAR) Advances TH104 to Combat Fentanyl Threats